Transition Therapeutics Inc (NASDAQ:TTHI)

2.11
Delayed Data
As of Jul 01
 +0.01 / +0.48%
Today’s Change
2.02
Today|||52-Week Range
9.30
-69.14%
Year-to-Date

Today’s Trading

Previous close2.10
Today’s open2.15
Day’s range2.02 - 2.15
Volume225,843
Average volume (3 months)147,427
Market cap$81.6M
Dividend yield--
Data as of 3:59pm ET, 07/01/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-59.47%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc+0.09+4.11%
GALTGalectin Therapeutic...-0.11-4.03%
GBSNUGreat Basin Scientif...0.000.00%
TROVUTrovagene Inc0.000.00%
Data as of 3:59pm ET, 07/01/2015

Financials

Next reporting dateSeptember 28, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
President &
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers